STOCK TITAN

AbbVie to Present at the Morgan Stanley Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

AbbVie will participate in the Morgan Stanley Virtual 19th Annual Global Healthcare Conference on September 15, 2021, at 9:15 a.m. Central time. Key executives including Richard A. Gonzalez and Michael Severino will be presenting.

A live audio webcast will be available on AbbVie's Investor Relations website, with an archived version accessible later that day. AbbVie focuses on developing innovative medicines in areas such as immunology, oncology, and neuroscience, emphasizing impactful health solutions.

Positive
  • None.
Negative
  • None.

NORTH CHICAGO, Ill., Sept. 9, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Morgan Stanley Virtual 19th Annual Global Healthcare Conference on Wednesday, September 15, 2021. Richard A. Gonzalez, chairman and chief executive officer, Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present at 9:15 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

Cision View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-morgan-stanley-healthcare-conference-301372019.html

SOURCE AbbVie

FAQ

When will AbbVie present at the Morgan Stanley Healthcare Conference?

AbbVie will present on September 15, 2021, at 9:15 a.m. Central time.

Who are the key executives presenting for AbbVie?

The presentation will feature Richard A. Gonzalez, Michael Severino, Robert A. Michael, and Jeffrey R. Stewart.

How can I access AbbVie's presentation at the conference?

You can access a live audio webcast of AbbVie's presentation through their Investor Relations website.

What are AbbVie's main therapeutic areas of focus?

AbbVie focuses on immunology, oncology, neuroscience, eye care, virology, women's health, and gastroenterology.

Where can I find more information about AbbVie?

More information can be found on AbbVie's website at www.abbvie.com.

ABBVIE INC.

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Stock Data

294.35B
1.77B
0.1%
73.43%
1.03%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
NORTH CHICAGO